LifeMD, Inc. (LFMDP) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

LifeMD, Inc. (LFMDP) Healthcare & Pipeline Overview

LifeMD, Inc. is a direct-to-patient telehealth company offering virtual primary, urgent, and specialized care across multiple brands like ShapiroMD, RexMD, and Nava MD. Leveraging a subscription-based model and e-commerce, it provides accessible healthcare solutions, including prescription services and diagnostics, alongside its PDFSimpli SaaS platform.

What Is the Investment Thesis for LFMDP?

LifeMD, Inc. operates with a direct-to-patient telehealth model, leveraging a diverse portfolio of specialized brands and a subscription-based primary care platform, which positions it to capitalize on the growing adoption of virtual healthcare. The company demonstrates strong operational efficiency with a gross margin of 85.9%, indicating effective cost management relative to its service revenue. Key growth catalysts include the continued expansion of its specialized telehealth offerings into new markets or conditions, and scaling its subscription-based LifeMD Primary Care platform to drive recurring revenue. However, investors must consider the competitive telehealth market and the company's current negative profit margin of -7.4%, which suggests ongoing investments in growth and potential challenges in achieving profitability. The stock's Beta of 1.99 also indicates higher volatility, necessitating careful risk assessment for its $158M market capitalization.

Based on FMP financials and quantitative analysis

LFMDP Key Highlights

Gross Margin: 85.9%, demonstrating strong cost control relative to revenue from its telehealth services.

• Market Capitalization: $0.16 billion, reflecting its current valuation within the telehealth and SaaS sectors.
• Profit Margin: -7.4%, indicating ongoing investments in growth and operational scaling despite current unprofitability.
• Employee Base: 304 employees, supporting its comprehensive direct-to-patient telehealth operations and SaaS platform.
• Beta: 1.99, suggesting higher stock price volatility compared to the broader market.

Who Are LFMDP's Competitors?

LFMDP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are LFMDP's Key Strengths?

Diversified portfolio of specialized telehealth brands (ShapiroMD, RexMD, LifeMD Primary Care, Cleared, Nava MD).

• High gross margin of 85.9%, indicating efficient service delivery and strong unit economics.
• Direct-to-patient model with established e-commerce and third-party partner networks for broad reach.
• Inclusion of a non-healthcare SaaS platform (PDFSimpli) providing revenue diversification and stability.

What Are LFMDP's Weaknesses?

Negative profit margin of -7.4%, highlighting current unprofitability and significant operational investments.

• High Beta of 1.99, suggesting considerable stock price volatility compared to the broader market.
• Dependence on a highly competitive and rapidly evolving telehealth market.
• Potential challenges in managing marketing expenses effectively to acquire and retain subscribers.

What Could Drive LFMDP Stock Higher?

LFMDP catalyst: Increasing adoption of telehealth services driven by convenience, accessibility, and evolving patient preferences across the United States.

• Expansion of subscription-based primary care and specialized health programs, fostering recurring revenue streams and customer loyalty.
• Potential for new product or service launches within its existing portfolio of telehealth brands, targeting unmet medical needs.
• Strategic initiatives focused on enhancing user acquisition and retention in the highly competitive telehealth market through optimized marketing and service quality.

What Are the Key Risks for LFMDP?

Financial-distress signal — its Altman Z-Score of -1.88 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Intense competition within the direct-to-patient telehealth market, potentially leading to increased marketing costs and pressure on market share.
• Challenges in achieving and sustaining profitability, as indicated by the current -7.4% profit margin, requiring effective management of operational and marketing expenses.
• Regulatory changes impacting telehealth operations, prescription fulfillment, and patient data privacy, which could necessitate significant adjustments to its business model.
• High stock price volatility, as indicated by a Beta of 1.99, exposing investors to greater market fluctuations and potential capital risk.

What Are the Growth Opportunities for LFMDP?

• Expanding Subscription-Based Primary Care: LifeMD Primary Care, a mobile-first, subscription-based platform, represents a significant growth avenue. The virtual primary care market is experiencing robust expansion, driven by increasing patient preference for convenience and cost-effectiveness. By scaling this platform, LifeMD can secure recurring revenue streams and enhance customer lifetime value through integrated online consultations, prescription services, diagnostics, and imaging. This model fosters patient loyalty and provides a stable foundation for long-term growth in the evolving healthcare landscape.
• Specialized Telehealth Brand Expansion: The company's portfolio of distinct telehealth brands, including ShapiroMD for hair loss, RexMD for men's health, Cleared for allergy/asthma, and Nava MD for tele-dermatology, targets specific, often underserved, market niches. Continued investment in developing and expanding these specialized offerings, potentially by introducing new treatments or conditions, allows LifeMD to capture market share in high-demand segments. This focused approach enables deeper expertise and more effective marketing within these distinct healthcare verticals.
• Leveraging the PDFSimpli SaaS Platform: While primarily a healthcare company, LifeMD's ownership of PDFSimpli, an online software-as-a-service (SaaS) platform for PDF document management, offers a unique diversification strategy. The global SaaS market continues to grow, providing an opportunity for LifeMD to expand PDFSimpli's user base, develop new features, and explore enterprise solutions. This non-healthcare revenue stream can contribute to overall financial resilience and provide a hedge against potential fluctuations in the telehealth sector, enhancing the company's overall market position.
• Strategic Partnerships and E-commerce Channels: LifeMD distributes its products and services directly to consumers, through e-commerce channels, and via third-party partner networks. Expanding and optimizing these strategic partnerships, such as collaborations with employers, health plans, or other healthcare providers, could significantly broaden its market reach and customer acquisition capabilities. Enhancing its e-commerce platforms to improve user experience and conversion rates also presents a direct path to increasing sales and subscriber numbers for its various brands.
• Innovation in Telehealth Technology and Service Offerings: The telehealth sector is characterized by continuous technological advancements and evolving service delivery models. LifeMD's direct-to-patient model allows for agile adaptation and integration of new technologies, such as AI-driven personalized care, remote monitoring devices, or expanded diagnostic capabilities. Investing in research and development to enhance existing platforms and introduce innovative services can strengthen its competitive advantage, attract new users, and improve patient outcomes, ensuring its offerings remain at the forefront of virtual healthcare.

What Threats Does LFMDP Face?

• Intense and increasing competition within the direct-to-patient telehealth market.
• Potential for adverse regulatory changes impacting telehealth operations, prescription services, and data privacy.
• Challenges in maintaining subscriber growth and managing customer acquisition costs in a competitive environment.
• Economic downturns potentially impacting consumer discretionary spending on healthcare services.

What Are LFMDP's Competitive Advantages?

• A diversified portfolio of distinct, specialized telehealth brands targeting specific, high-demand health niches.
• Direct-to-patient operational model, enabling efficient service delivery and direct customer relationship management.
• Integration of prescription services, diagnostics, and imaging capabilities within its virtual care platforms.
• Diversification of revenue streams through the inclusion of the PDFSimpli SaaS platform, outside of core healthcare.
• Established e-commerce and third-party partner networks providing broad distribution and market access.

What Does LFMDP Do?

LifeMD, Inc. functions as a direct-to-patient telehealth enterprise, linking individuals with healthcare professionals throughout the United States for a diverse array of medical concerns. Initially established in 1994 as Conversion Labs, Inc., the company officially rebranded to LifeMD, Inc. in February 2021, evolving into a prominent player in the virtual healthcare landscape. Its services encompass everything from personalized concierge care to specialized fields such as men's sexual health and dermatology, all delivered through a portfolio of distinct telehealth brands. ShapiroMD is dedicated to comprehensive hair loss solutions, offering virtual consultations, prescription medications, unique over-the-counter products, an FDA-approved medical device, and specialized compounded topical treatments for both male and female hair loss. RexMD provides virtual medical treatment from licensed providers for various men's health requirements. LifeMD Primary Care is a subscription-based, mobile-first platform delivering personalized virtual primary, urgent, and chronic care, integrating online consultations, prescription services, diagnostics, and imaging. Cleared focuses on customized treatments for allergy, asthma, and immunological conditions. Nava MD serves as a female-oriented tele-dermatology and skincare brand, facilitating virtual medical consultations with dermatologists and other experts. Beyond its core healthcare focus, LifeMD also manages PDFSimpli, an online software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents. The company distributes its products and services directly to consumers, through e-commerce channels, and via third-party partner networks, with its corporate headquarters located in New York, New York, and a workforce of 304 employees.

What Products and Services Does LFMDP Offer?

• Connect patients with licensed healthcare professionals virtually across the United States.
• Offer specialized telehealth services for men's sexual health through RexMD and dermatology for women via Nava MD.
• Provide comprehensive hair loss solutions through ShapiroMD, including virtual consultations, prescriptions, and medical devices.
• Deliver subscription-based virtual primary, urgent, and chronic care via its LifeMD Primary Care platform.
• Customize treatments for allergy, asthma, and immunological conditions through its Cleared brand.
• Manage PDFSimpli, an online software-as-a-service (SaaS) platform for creating, editing, and sharing PDF documents.
• Distribute its healthcare products and services directly to consumers, through e-commerce, and via third-party partner networks.

How Does LFMDP Make Money?

• Operates a direct-to-patient telehealth model, facilitating virtual consultations with licensed healthcare providers.
• Generates revenue through subscription-based services for primary care and specialized health programs.
• Sells prescription medications, over-the-counter products, and medical devices directly to consumers via e-commerce.
• Earns revenue from its online software-as-a-service (SaaS) platform, PDFSimpli, through user subscriptions or purchases.
• Utilizes third-party partner networks to expand distribution and reach for its various healthcare offerings.

What Industry Does LFMDP Operate In?

LifeMD, Inc. operates within the dynamic and rapidly expanding healthcare sector, specifically in the medical pharmaceuticals industry through its direct-to-patient telehealth model. The broader telehealth market is experiencing significant growth, driven by increasing consumer demand for convenient, accessible, and often more affordable healthcare solutions. LifeMD positions itself by offering a portfolio of specialized telehealth brands, such as ShapiroMD for hair loss and RexMD for men's health, alongside its general LifeMD Primary Care subscription service. This strategy allows the company to target specific market niches while also providing broader virtual primary care. The competitive landscape for telehealth is becoming increasingly crowded, with numerous players vying for market share. LifeMD's ability to maintain subscriber growth and manage marketing expenses will be critical in this environment, as the growing adoption of telehealth presents both a significant opportunity for user acquisition and a challenge due to heightened competition.

Who Are LFMDP's Key Customers?

• Individuals seeking convenient virtual primary, urgent, and chronic care services.
• Men requiring specialized health solutions, particularly for sexual health and hair loss.
• Women seeking tele-dermatology and skincare consultations or hair loss treatments.
• Individuals with allergy, asthma, and immunological conditions looking for customized virtual care.
• General consumers and businesses utilizing PDFSimpli for document creation, editing, and management.

Wall Street analysts project LifeMD, Inc. revenue of about $217.2M for fiscal 2026, with EPS near $-0.43. The estimate reflects 8 contributing analysts.

Quarterly Financial Performance: LifeMD, Inc.

Revenue for LifeMD, Inc. came in at $47.3M during Q2 2026, a 5.7% contraction versus the preceding quarter. The company recorded a net loss of $7.1M, with diluted EPS of $-0.16. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, LFMDP averaged $-0.13 in diluted EPS.

LFMDP Valuation & Market Position

With a $158M market cap, LifeMD, Inc. sits in the micro-cap segment of the market. Relative to its peer group, LFMDP's quantitative score of 19/100 is below the peer average of 49/100.

Key Financial Metrics

Return on assets is -35.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -4.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.90 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -12.9%, the inverse of the P/E and a quick read on earnings relative to price.

LifeMD, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.88 places it in the distress zone, a signal of elevated financial risk.

LifeMD, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 0.9% below estimates on average.

Company Profile

LifeMD, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Justin Schreiber. LFMDP has traded publicly since 2021.

LFMDP Financials

LFMDP Latest News

No recent news available for LFMDP.

LFMDP Analyst Consensus

LFMDP MoonshotScore

What Investors Ask About LifeMD, Inc. (LFMDP) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources